MoneyWorks4Me

Astrazeneca Pharma I - Quaterly Results

11 Nov 2022 Evaluate
The revenue zoomed 19.43% to Rs. 2361.27 millions for the quarter ended September 2022 as compared to Rs. 1977.08 millions during the corresponding quarter last year.The Total revenue for the quarter ended September 2022 of  Rs. 325.66  millions  grew by 172.61% from Rs. 119.46 millions.Operating profit surged to 475.20 millions from the corresponding previous quarter of 207.59 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 2361.27 1977.08 19.43 4684.59 3731.10 25.56 8056.00 8135.63 -0.98
Other Income 67.94 28.43 138.97 109.08 57.42 89.97 147.58 128.41 14.93
PBIDT 475.20 207.59 128.91 795.98 392.89 102.60 1009.33 1483.12 -31.95
Interest 1.62 2.47 -34.41 3.48 5.13 -32.16 9.47 10.93 -13.36
PBDT 473.58 205.12 130.88 792.50 387.76 104.38 999.86 1472.19 -32.08
Depreciation 32.87 42.76 -23.13 78.79 90.37 -12.81 169.49 201.26 -15.79
PBT 440.71 162.36 171.44 713.71 297.39 139.99 830.37 1270.93 -34.66
TAX 115.05 42.90 168.18 186.50 75.51 146.99 214.43 337.90 -36.54
Deferred Tax -8.95 -4.82 85.68 -14.24 -13.88 2.59 -11.86 -10.38 14.26
PAT 325.66 119.46 172.61 527.21 221.88 137.61 615.94 933.03 -33.98
Equity 50.00 50.00 0.00 50.00 50.00 0.00 50.00 50.00 0.00
PBIDTM(%) 20.12 10.50 91.67 16.99 10.53 61.36 12.53 18.23 -31.27
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..